University of St Andrews

Mackenzie Institute for Early Diagnosis

Publications

100 (of 1000 /dk/atira/pure/researchoutput/status/published available) for Sir James Mackenzie Institute for Early Diagnosis (source: University of St Andrews PURE)
Please click title of any item for full details

Effectiveness of universal school-based programs for prevention of violence in adolescents Anna Jane Gavine, Peter Duncan Donnelly, Damien John Williams
Psychology of Violence 2016 vol. 6 pp. 390-399
Crosstalk between zinc and fatty acids in plasma James P C Coverdale, Siavash Khazaipoul, Swati Arya, Alan J. Stewart, Claudia A Blindauer
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 2019 vol. 1864 pp. 532-542
Raman spectroscopy investigation of biochemical changes in tumor spheroids with aging and after treatment with staurosporine Lauren E. Jamieson, David James Harrison, Colin J. Campbell
Journal of Biophotonics 2019 vol. 12
Impact of clinical trial findings on Bell's palsy management in general practice in the UK 2001-2012 Daniel Ramon Morales, Peter T Donnan, Fergus Daly, Tjeerd Van Staa, Frank Sullivan
BMJ Open 2013 vol. 3
Podiatry interventions to prevent falls in older people Gavin Wylie, Claire Torrens, Pauline Campbell, Helen Frost, Adam Lee Gordon, Hylton B. Menz, Dawn A. Skelton, Frank Sullivan, Miles D. Witham, Jacqui Morris
Age and Ageing 2019 vol. 48 pp. 327–336
Patient centred consultation, satisfaction and young patients Aldo Alberto Conti, Gerald Michael Humphris
Patient Education and Counseling 2019 vol. 102 pp. 782-789
Modelling reassurances of clinicians with Hidden Markov models Valentin Mina Popov, Alesha Bradley, Gerald Michael Humphris
BMC Medical Research Methodology 2019 vol. 19
Deciphering the genomic, epigenomic and transcriptomic landscapes of pre-invasive lung cancer lesions Vitor H. Texeira, Chrisodoulos P. Pipinikas, Adam Pennycuick, Henry Lee-Six, Deepak Chandrasekharan, Jennifer Beane, Tiffany J. Morris, Anna Karpathakis, Andrew Feber, Charles E. Breeze, Paschalis Ntolios, Robert E. Hynds, Mary Falzon, Arrigo Capitanio, Bernadette Carroll, Pascal F. Durrenberger, Georgia Hardavella, James M. Brown, Andy Lynch, Henry Farmery, Dirk S. Paul, Rachel C. Chambers, Nicholas McGranahan, Neal Navani, Ricky M. Thakrar, Charles Swanton, Stephan Beck, Philip Jeremy George, Avrum Spira, Peter J. Campbell, Christina Thirwell, Sam M. Jones
Nature Medicine 2019 vol. 25 pp. 517-525
Total plasma magnesium, zinc, copper and selenium concentrations in type-I and type-II diabetes Amelie Isabelle Sylvie Sobczak, Fiona Stefanowicz, Samantha J. Pitt, Ramzi A. Ajjan, Alan J. Stewart
BioMetals 2019 vol. 32 pp. 123-138
Agreement between primary care and hospital diagnosis of schizophrenia and bipolar disorder Braden O’Neill, Sumeet Kalia, Babak Aliarzadeh, Rahim Moineddin, Wai Lun Alan Fung, Frank Sullivan, Asmaa Maloul, Steven Bernard, Michelle Greiver
PLoS ONE 2019 vol. 14
Developing the International Association for Communication in Healthcare (EACH) to address current challenges of health communication Sara Rubinelli, Jonathan Silverman, Karolien Aelbrecht, Myriam Deveugele, Arnstein Finset, Gerald Michael Humphris, Peter Martin, Marcy Rosenbaum, Sandra van Dulmen, Evelyn van Weel-Baumgarten
Patient Education and Counseling 2019 vol. 102 pp. 1217-1221
Fear of cancer recurrence in adolescent and young adult cancer survivors Yuan Yang, Wen Li, Yunhong Wen, Hongmei Wang, Henwen Sun, Weijiang Liang, Bin Zhang, Gerald Michael Humphris
Psycho-Oncology 2019 vol. 28 pp. 675-686
Heat-inactivation renders sputum safe and preserves Mycobacterium tuberculosis RNA for downstream molecular tests Wilber Sabiiti, Khalide Azam, Ezembro Esmeraldo, Nilesh Bhatt, Andrea Rachow, Stephen Henry Gillespie
Journal of Clinical Microbiology 2019 vol. 57
Automated analysis of lymphocytic infiltration, tumor budding, and their spatial relationship improves prognostic accuracy in colorectal cancer Ines Nearchou, Kate Lillard, Hideki Ueno, David James Harrison, Peter David Caie
Cancer Immunology Research 2019 vol. 7 pp. 609-620
Automated screening for distress Rajib Rana, Saddique Latif, Raj Gururajan, Anthony Gray, Geraldine Mackenzie, Gerald Michael Humphris, Jeff Dunn
European Journal of Cancer Care 2019 vol. 28
Communication skills training for the radiotherapy team to manage cancer patients’ emotional concerns Mara Myrthe van Beusekom, Josie Cameron, Carolyn Bedi, Elspeth Banks, Gerald Michael Humphris
BMJ Open 2019 vol. 9
Quantitative proteomic changes in LPS-activated monocyte-derived dendritic cells Swati Arya, Silvia Anna Synowsky, Sally Lorna Shirran, Catherine Helen Botting, Simon John Powis, Alan J. Stewart
Scientific Reports 2019 vol. 9
Trends in end digit preference for blood pressure and associations with cardiovascular outcomes in Canadian and UK primary care Michelle Greiver, Sumeet Kalia, Teja Voruganti, Babak Aliarzadeh, Rahim Moineddin, William Hinton, Martin Dawes, Frank Sullivan, Saddaf Syed, John Williams, Simon De Lusignan
BMJ Open 2019 vol. 9
Automated tumour budding quantification by machine learning augments TNM staging in muscle-invasive bladder cancer prognosis Nicolas Brieu, Ines Nearchou, David James Harrison, Günter Schmidt, Peter David Caie
Scientific Reports 2019 vol. 9
Adherence Anita Helen Laidlaw
2019 pp. 92
The impact of treatment adherence for patients with diabetes and hypertension on cardiovascular disease risk Min Su, Victoria Haldane, Ross Upshur, Frank Sullivan, France L.A. Garda, Michelle Greiver, Xiaolin Wei
JMIR Research Protocols 2019 vol. 8
Specialist breast cancer nurses' views on implementing a fear of cancer recurrence intervention in practice Susanne Cruickshank, Emma Steele, Debbie Fenlon, Jo Arnes, Elspeth Banks, Gerald Michael Humphris
Supportive Care in Cancer 2020 vol. 28 pp. 201–210
Factors associated with recruitment to randomised controlled trials in general practice Keith Rafie Moffat, Paul Cannon, Wen Shi, Frank Sullivan
Trials 2019 vol. 20
Glutaminase inhibition in renal cell carcinoma therapy Paul Andrew Reynolds
Cancer Drug Resistance 2019 vol. 2
Strong light-matter coupling for reduced photon energy losses in organic photovoltaics Vasileios C. Nikolis, Andreas Mischok, Bernhard Siegmund, Jonas Kublitski, Xiangkun Jia, Johannes Benduhn, Ulrich Hörmann, Dieter Neher, Malte Christian Gather, Donato Spoltore, Koen Vandewal
Nature Communications 2019 vol. 10
Molecular bacterial load assay (MBLA) concurs with culture on the NaOH-induced Mycobacterium tuberculosis loss of viability Wilber Sabiiti, Issa Sabi, Joseph John, Emanuel Sichone, Nyanda E. Ntinginya, Stephen Henry Gillespie
Journal of Clinical Microbiology 2019 vol. 57
Participatory governance over research in an academic research network Donald J Willison, Joslyn Trowbridge, Michelle Greiver, Karim Keshavjee, Doug Mumford, Frank Sullivan
BMJ Open 2019 vol. 9
MCM-2 CELL BASED ASSAY IS A SENSITIVE AND SPECIFIC TEST FOR RISK STRATIFICATION OF BLADDER CANCER PATIENTS. Kasra Saeb-Parsy, Peter David Caie, Durgesh Rana, Nadira Narine, Bensita Thottakam, Sushant Dhanvhijay, Andrew Ball, Alexander Wilson, David James Harrison
2017
Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031 In Hwa Um, Tsz Huen Chan, Peter Mullen, David James Harrison, Paul Andrew Reynolds
Scientific Reports 2019 vol. 9
Novel internationally verified method reports desmoplastic reaction as the most significant prognostic feature for disease-specific survival in stage II colorectal cancer Ines Nearchou, Yoshiki Kajiwara, Satsuki Mochizuki, David James Harrison, Peter David Caie, Hideki Ueno
American Journal of Surgical Pathology 2019 vol. 43 pp. 1239-1248
Ni vs. Pd in Suzuki-Miyaura sp2-sp2 cross-coupling Allan John Bell Watson
Organic & Biomolecular Chemistry 2019 vol. 17 pp. 5055-5059
Honeybee activity monitoring in a biohybrid system for explosives detection Mitar Simić, Ross Gillanders, Aleksej Avramović, Slavica Gajić, Vedran Jovanović, Vladan Stojnić, Vladimir Risojević, Graham Turnbull, Janja Filipi, Nikola Kezić, Mario Muštra, Zdenka Babić
2019 pp. 185-192
Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer Spela Mirosevic, Belinda Thewes, Carla van Herpen, Johannes Kaanders, Thijs Merkx, Gerald Michael Humphris, Robert J. Baatenburg de Jong, Johannes A. Langendijk, C. René Leemans, Chris H. J. Terhaard, Irma M. Verdonck-de Leeuw, Robert Takes, Judith Prins,
Head and Neck 2019 vol. 41 pp. 3187-3200
A decade of life-course research on fertility of immigrants and their descendants in Europe Hill Kulu, Nadja Milewski, Tina Hannemann, Julia Mikolai
Demographic Research 2019 vol. S23 pp. 1345-1374
Recording communication in primary dental practice Siyang Yuan, Gerald Michael Humphris, Alastair Ross, Lorna MacPherson, Ruth Freeman
British Dental Journal 2019 vol. 227 pp. 887–892
Comment TB - Strength in numbers Geoffrey D. Coxon, Stephen Henry Gillespie
Microbiology Today 2010 vol. 37
Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London David M. Livermore, Robert L.R. Hill, Hazel Thomson, André Charlett, Jane F. Turton, Rachel Pike, Bharat C. Patel, Rohini Manuel, Stephen Henry Gillespie, Indran Balakrishnan, Stephen P. Barrett, Nigel Cumberland, Mary Twagira,
International Journal of Antimicrobial Agents 2010 vol. 35 pp. 19-24
The effect of oxidative stress on the mutation rate of Mycobacterium tuberculosis with impaired catalase/peroxidase function Denise M. O'Sullivan, Timothy D. McHugh, Stephen Henry Gillespie
Journal of Antimicrobial Chemotherapy 2008 vol. 62 pp. 709-712
The ethics of non-inferiority trials Andrew J. Nunn, Sarah K. Meredith, Melvin K. Spigelman, Ann M. Ginsberg, Stephen Henry Gillespie
The Lancet 2008 vol. 371
Fluoroquinolone-resistant mutants of Burkholdena cepacia C. F. Pope, Stephen Henry Gillespie, J. R. Pratten, Timothy D. McHugh
Antimicrobial Agents and Chemotherapy 2008 vol. 52 pp. 1201-1203
Moxifloxacin Stephen Henry Gillespie
Therapy 2007 vol. 4 pp. 813-820
Tuberculosis Stephen Henry Gillespie
Biochemical Society Transactions 2007 vol. 35 pp. 1317-1320
IκB genetic polymorphisms and invasive pneumococcal disease Stephen J. Chapman, Chiea C. Khor, Fredrik O. Vannberg, Angela Frodsham, Andrew Walley, Nicholas A. Maskell, Christopher W.H. Davies, Shelley Segal, Catrin E. Moore, Stephen Henry Gillespie, Paul Denny, Nicholas P. Day, Derrick W. Crook, Robert J.O. Davies, Adrian V.S. Hill
American Journal of Respiratory and Critical Care Medicine 2007 vol. 176 pp. 181-187
Prevalences of Pneumocystis jiroveci, Mycobacterium tuberculosis and Streptococcus pneumoniae infection in children with severe pneumonia, in a tertiary referral hospital in northern Tanzania J. Uriyo, R. D. Gosling, V. Maddox, N. E. Sam, W. Schimana, Stephen Henry Gillespie, Timothy D. McHugh
Annals of Tropical Medicine and Parasitology 2006 vol. 100 pp. 245-249
Quantitative Validation of Media for Transportation and Storage of Streptococcus pneumoniae B. M. Charalambous, S. L. Batt, A. C. Peek, H. Mwerinde, N. E. Sam, Stephen Henry Gillespie
Journal of Clinical Microbiology 2003 vol. 41 pp. 5551-5556
Evolutionary relationships among strains of Mycobacterium tuberculosis with few copies of IS6110 Jeremy W. Dale, Hasan Al-Ghusein, Salim Al-Hashmi, Philip Butcher, Anne L. Dickens, Francis Drobniewski, Ken J. Forbes, Stephen Henry Gillespie, Dianie Lamprecht, Timothy D. McHugh, Richard Pitman, Nalin Rastogi, Andrew T. Smith, Christophe Sola, Hasan Yesilkaya
Journal of Bacteriology 2003 vol. 185 pp. 2555-2562
The Bactericidal Activity of Moxifloxacin in Patients with Pulmonary Tuberculosis R. D. Gosling, Leonard O. Uiso, N. E. Sam, Emily Bongard, Esther C. Kanduma, Mramba Nyindo, Richard W. Morris, Stephen Henry Gillespie
American Journal of Respiratory and Critical Care Medicine 2003 vol. 168 pp. 1342-1345
Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission H. Maguire, Jeremy W. Dale, Timothy D. McHugh, Philip Butcher, Stephen Henry Gillespie, A. Costetsos, Hasan Al-Ghusein, R. Holland, Anne L. Dickens, L. Marston, Paul Joseph Wilson, Robert Maurice Pitman, D. Strachan, Francis Drobniewski, D. K. Banerjee
Journal of Clinical Pathology - Molecular Pathology 2003 vol. 56 pp. 121-126
Prospective evaluation of BDProbeTec strand displacement amplification (SDA) system for diagnosis of tuberculosis in non-respiratory and respiratory samples Timothy D. McHugh, C. F. Pope, C. L. Ling, S. Patel, O. J. Billington, R. D. Gosling, Stephen Henry Gillespie
Journal of Medical Microbiology 2004 vol. 53 pp. 1215-1219
Human Immunodeficiency Virus Type 1-Related Pulmonary Mycobacterium xenopi Infection L. Kerbiriou, A. Ustianowski, M. A. Johnson, Stephen Henry Gillespie, R. F. Miller, M. C.I. Lipman
Clinical Infectious Diseases 2003 vol. 37 pp. 1250-1254
Cutaneous larva migrans Stephen Henry Gillespie
Current Infectious Disease Reports 2004 vol. 6 pp. 50-53
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP) C. Chintu, G. J. Bhat, Alan Melville Walker, V. Mulenga, F. Sinyinza, K. Lishimpi, L. Farrelly, N. Kaganson, A. Zumla, Stephen Henry Gillespie, Andrew J. Nunn, Diana M. Gibb
Lancet 2004 vol. 364 pp. 1865-1871
The interpretation of nucleic acid amplification tests for tuberculosis S. J. Conaty, A. P. Claxton, D. A. Enoch, Amy Louise Hayward, Stephen Henry Gillespie
Journal of Infection 2005 vol. 50 pp. 187-192
Novel PCR-restriction fragment length polymorphism method for determining serotypes or serogroups of Streptococcus pneumoniae isolates S. L. Batt, B. M. Charalambous, Timothy D. McHugh, Siobhan Martin, Stephen Henry Gillespie
Journal of Clinical Microbiology 2005 vol. 43 pp. 2656-2661
Studies of early bactericidal activity Stephen Henry Gillespie
Clinical Infectious Diseases 2004 vol. 39 pp. 1431-1432
Antibiotic resistance markers in genetically modified plants Philippe B. Gay, Stephen Henry Gillespie
Lancet Infectious Diseases 2005 vol. 5 pp. 637-646
BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment L. P. Ormerod, H. J. Milburn, Stephen Henry Gillespie, J. Ledingham, D. Rampton
Thorax 2005 vol. 60 pp. 800-805
PTPN22 and invasive bacterial disease [1] Stephen J. Chapman, Chiea C. Khor, Fredrik O. Vannberg, Nicholas A. Maskell, Christopher W.H. Davies, Emma L. Hedley, Shelley Segal, Catrin E. Moore, Kyle Knox, Nicholas P. Day, Stephen Henry Gillespie, Derrick W. Crook, Robert J.O. Davies, Adrian V.S. Hill
Nature Genetics 2006 vol. 38 pp. 499-500
A new world approach to an old infection Felicity Perrin, Stephen Henry Gillespie
Good Clinical Practice Journal 2006 vol. 13 pp. 18-21
Direct detection of heteroresistance in Mycobacterium tuberculosis using molecular techniques Mairi M. Cullen, N. E. Sam, Esther G. Kanduma, Timothy D. McHugh, Stephen Henry Gillespie
Journal of Medical Microbiology 2006 vol. 55 pp. 1157-1158
Escherichia coli and Shigella spp. Christopher L. Baylis, Charles W. Penn, Nathan M. Thielman, Richard L. Guerrant, Claire Jenkins, Stephen Henry Gillespie
2006 pp. 347-365
Surgically important organisms Stephen Henry Gillespie
Foundation Years 2006 vol. 2 pp. 233-236
Preface Stephen Henry Gillespie, Peter M. Hawkey
2006 pp. ix
Non-tuberculosis mycobacteria Stephen Henry Gillespie
2006 pp. 171-181
Salmonella spp. Claire Jenkins, Stephen Henry Gillespie
2006 pp. 367-376
Aerobic Actinomycetes Stephen Henry Gillespie
2006 pp. 183-188
Molecular strain typing of M. tuberculosis isolates from a suspected outbreak involving a faulty bronchoscope [3] R. J. Shorten, Stephen Henry Gillespie, O. Sule, Timothy D. McHugh
Journal of Hospital Infection 2005 vol. 61 pp. 86-87
Moxifloxacin treatment of tuberculosis [2] (multiple letters) R. D. Gosling, Stephen Henry Gillespie, Mathias W.R. Pletz, Hartmut Lode
Antimicrobial Agents and Chemotherapy 2004 vol. 48 pp. 3642-3643
Clinical and therapeutic management of pulmonary Mycobacterium xenopi infection in HIV-positive patients [3] (multiple letters) Lidia Gazzola, Miriam Cesari, Franco Salerno, Fabio Franzetti, Andrea Gori, L. Kerbiriou, A. Ustianowski, Margaret Johnson, Stephen Henry Gillespie, R. F. Miller, M. Lipman
Clinical Infectious Diseases 2004 vol. 38 pp. 1642-1644
New tricks from an old dog Stephen Henry Gillespie
Lancet 2004 vol. 363 pp. 672-673
A multicentre comparison of a novel surrogate marker for determining the specific potency of anti-tuberculosis drugs R. D. Gosling, Leonid Heifets, Stephen Henry Gillespie
Journal of Antimicrobial Chemotherapy 2003 vol. 52 pp. 473-476
Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae S. L. Batt, B. M. Charalambous, Anthony W. Solomon, Charles Knirsch, Patrick A. Massae, Salesia Safari, N. E. Sam, Dean Everett, David C.W. Mabey, Stephen Henry Gillespie
Antimicrobial Agents and Chemotherapy 2003 vol. 47 pp. 2765-2769
Severe acute respiratory syndrome (SARS) Peter M. Hawkey, Sanjay Bhagani, Stephen Henry Gillespie
Journal of Medical Microbiology 2003 vol. 52 pp. 609-613
A novel method for evaluating the antimicrobial activity of tuberculosis treatment regimens Stephen Henry Gillespie, B. M. Charalambous
International Journal of Tuberculosis and Lung Disease 2003 vol. 7 pp. 684-689
Molecular methods for Mycobacterium tuberculosis strain typing Esther G. Kanduma, Timothy D. McHugh, Stephen Henry Gillespie
Journal of Applied Microbiology 2003 vol. 94 pp. 781-791
Criteria for identification of cross-contamination of cultures of Mycobacterium tuberculosis in routine microbiology laboratories [4] (multiple letters) Nora M. Carroll, Madalene Richardson, Paul D. Van Helden, Stephen Henry Gillespie, Timothy D. McHugh, Anette S. De Boer, Dick Van Soolingen
Journal of Clinical Microbiology 2003 vol. 41 pp. 2269-2270
Fluoroquinolone resistance in Streptococcus pneumoniae Stephen Henry Gillespie, Leroy L. Voelker, Jane E. Ambler, Chris Traini, Anne L. Dickens
Microbial Drug Resistance 2003 vol. 9 pp. 17-24
Microbes sans frontières Stephen Henry Gillespie
Lancet 2002 vol. 359 pp. 93-95
New quinolones for respiratory infections Stephen Henry Gillespie, Morrissey
Round Table Series - Royal Society of Medicine 2002 pp. 3-7
Novel perspectives in antibacterial action Glenn S. Tillotson, Stephen Henry Gillespie
Round Table Series - Royal Society of Medicine 2002
Principles and Practice of Clinical Bacteriology Stephen Henry Gillespie, Peter M. Hawkey
2006
Tuberculosis drug development pipeline Melvin K. Spigelman, Stephen Henry Gillespie
Lancet 2006 vol. 367 pp. 945-947
Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century P. C. Appelbaum, Stephen Henry Gillespie, C. J. Burley, Glenn S. Tillotson
International Journal of Antimicrobial Agents 2004 vol. 23 pp. 533-546
Evolution of drug resistance in Mycobacterium tuberculosis Stephen Henry Gillespie
Antimicrobial Agents and Chemotherapy 2002 vol. 46 pp. 267-274
Multiple drug-resistant mycobacterium tuberculosis Stephen Henry Gillespie, O. J. Billington, Aodhan Breathnach, Timothy D. McHugh
Microbial Drug Resistance 2002 vol. 8 pp. 273-279
Purification of native α-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic G. C. Whiting, S. Patel, Stephen Henry Gillespie
Journal of Medical Microbiology 2002 vol. 51 pp. 837-843
A reitrerative method for calculating the early bactericidal activity of antituberculosis drugs Stephen Henry Gillespie, R. D. Gosling, B. M. Charalambous
American Journal of Respiratory and Critical Care Medicine 2002 vol. 166 pp. 31-35
Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae Stephen Henry Gillespie, Leroy L. Voelker, Anne L. Dickens
Microbial Drug Resistance 2002 vol. 8 pp. 79-84
Respiratory and cutaneous manifestations of disseminated cryptococcosis in AIDS [2] F. Islam, Stephen Henry Gillespie, F. Chua, M. Jarmulowicz, M. Johnson,
Sexually Transmitted Infections 2001 vol. 77 pp. 75-76
Antibiotic resistance in the absence of selective pressure Stephen Henry Gillespie
International Journal of Antimicrobial Agents 2001 vol. 17 pp. 171-176
A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model Stephen Henry Gillespie, Ian Morrissey, Dean Everett
Journal of Medical Microbiology 2001 vol. 50 pp. 565-570
Toxocara Stephen Henry Gillespie
British Journal of Sports Medicine 2001 vol. 35 pp. 6-7
Fluoroquinolones and tuberculosis [3] (multiple letters) W. W. Yew, C. H. Chau, Stephen Henry Gillespie, N. Kennedy
International Journal of Tuberculosis and Lung Disease 1998 vol. 2 pp. 1050-1052
Fluoroquinolones Stephen Henry Gillespie, N. Kennedy
International Journal of Tuberculosis and Lung Disease 1998 vol. 2 pp. 265-271
Comparison of variable number tandem repeat and IS6110-restriction fragment length polymorphism analyses for discrimination of high- and low-copy-number IS6110 Mycobacterium tuberculosis isolates R. E.L. Barlow, D. M. Gascoyne-Binzi, Stephen Henry Gillespie, Anne L. Dickens, S. Qamer, Peter M. Hawkey
Journal of Clinical Microbiology 2001 vol. 39 pp. 2453-2457
Management of invasive pulmonary aspergillosis in hematology patients T. Yeghen, C. C. Kibbler, T. Yeghen, H. G. Prentice, L. A. Berger, R. K. Wallesby, P. H.M. McWhinney, F. C. Lampe, Stephen Henry Gillespie
Clinical Infectious Diseases 2000 vol. 31 pp. 859-868

X